↓ Skip to main content

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Overview of attention for article published in Breast Cancer Research, February 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
98 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population
Published in
Breast Cancer Research, February 2018
DOI 10.1186/s13058-018-0942-x
Pubmed ID
Authors

Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J. Battista, Annette Hasenburg, Ugur Sahin, Konstantine T. Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M. Wirtz, Heikki Joensuu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 98 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 11%
Researcher 11 11%
Student > Bachelor 11 11%
Professor 8 8%
Other 4 4%
Other 18 18%
Unknown 35 36%
Readers by discipline Count As %
Medicine and Dentistry 19 19%
Biochemistry, Genetics and Molecular Biology 9 9%
Nursing and Health Professions 6 6%
Agricultural and Biological Sciences 6 6%
Immunology and Microbiology 3 3%
Other 12 12%
Unknown 43 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2018.
All research outputs
#20,567,353
of 26,017,215 outputs
Outputs from Breast Cancer Research
#1,694
of 2,086 outputs
Outputs of similar age
#258,453
of 347,241 outputs
Outputs of similar age from Breast Cancer Research
#15
of 18 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,086 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,241 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.